• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Mettler-Toledo International Inc. Reports Fourth Quarter 2024 Results

    2/6/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $MTD alert in real time by email

    Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2024. Provided below are the highlights:

    • Reported and local currency sales increased 12% compared with the prior year.
    • Net earnings per diluted share as reported (EPS) were $11.96, compared with $8.52 in the prior-year period. Adjusted EPS was $12.41, an increase of 32% over the prior-year amount of $9.40. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules.

    Fourth Quarter Results

    Patrick Kaltenbach, President and Chief Executive Officer, stated, "We had a strong finish to the year as we capitalized on very good customer demand for Laboratory products, especially in Europe. Strong sales growth and solid execution of our margin improvement initiatives contributed to excellent Adjusted EPS and cash flow."

    GAAP Results

    EPS in the quarter was $11.96, compared with the prior-year amount of $8.52.

    Compared with the prior year, total reported sales rose 12% to $1.045 billion. By region, reported sales increased 6% in the Americas, 18% in Europe, and 15% in Asia/Rest of World. Earnings before taxes amounted to $314.5 million, compared with $232.6 million in the prior year.

    Non-GAAP Results

    Adjusted EPS was $12.41, an increase of 32% over the prior-year amount of $9.40.

    Compared with the prior year, total sales in local currency increased 12%. By region, local currency sales increased 7% in the Americas, 19% in Europe, and 14% in Asia/Rest of World. Excluding the impact from delayed fourth quarter 2023 shipments, sales in local currency increased 6%, including sales growth of 3% in the Americas, 8% in Europe, and 10% in Asia/Rest of World. Adjusted Operating Profit amounted to $351.9 million, compared with the prior-year amount of $281.8 million.

    Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.

    Full Year Results

    GAAP Results

    EPS was $40.48, compared with the prior-year amount of $35.90, and included a non-cash discrete tax benefit of $1.07 per share.

    Compared with the prior year, total reported sales increased 2% to $3.872 billion. By region, reported sales increased 2% in the Americas and 8% in Europe and declined 3% in Asia/Rest of World. Earnings before taxes amounted to $1.037 billion, compared with $973.7 million in the prior year.

    Non-GAAP Results

    Adjusted EPS was $41.11, an 8% increase from the prior-year amount of $38.03.

    Compared with the prior year, total sales in local currency grew 3% as currency reduced sales growth by 1%. By region, local currency sales increased 3% in the Americas and 8% in Europe and declined 1% in Asia/Rest of World. Excluding the impact from delayed fourth quarter 2023 shipments, local currency sales in 2024 were flat, including sales growth of 1% in the Americas and 2% in Europe and a decline of 3% in Asia/Rest of World. Adjusted Operating Profit amounted to $1.200 billion, a 4% increase compared with the prior-year amount of $1.152 billion.

    Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.

    Outlook

    Management cautions that market conditions are uncertain and could change quickly. Based on today's assessment, management anticipates local currency sales for the first quarter of 2025 will decline approximately 3% to 4%, which includes a headwind of approximately 6% from the previously disclosed shipping delays in the fourth quarter of 2023 that benefited the first quarter of 2024. Adjusted EPS is forecast to be $7.75 to $7.95, a decline of 11% to 13%, which includes headwinds of approximately 18% from the previously mentioned shipping delays and an estimated 2% due to adverse currency.

    For the full year 2025, management anticipates local currency sales will increase approximately 3%, which includes a headwind of approximately 1.5% from the previously disclosed shipping delays in the fourth quarter of 2023 that benefited the first quarter of 2024. Adjusted EPS is forecast to be in the range of $42.35 to $43.00, representing growth of approximately 3% to 5%, and includes headwinds of approximately 4% from the previously mentioned shipping delays and an estimated 2% due to adverse currency. This compares with previous local currency sales growth guidance of approximately 3% and Adjusted EPS guidance of $41.85 to $42.50.

    The Company does not provide GAAP financial measures on a forward-looking basis because we are unable to predict with reasonable certainty and without unreasonable effort the timing and amount of future restructuring and other non-recurring items.

    Conclusion

    Kaltenbach concluded, "We achieved good results in 2024 despite soft market conditions and continue to benefit from our strong culture of execution and continuous improvement. At the same time, we stayed focused on our long-term strategy of delivering innovative solutions and extending our market leadership. Driving growth is our top priority in 2025, and we will continue to build on our competitive strengths and take advantage of opportunities in automation, digitalization, and high-growth areas to further expand our market share and deliver good earnings growth."

    Other Matters

    The Company will host a conference call to discuss its quarterly results tomorrow morning (Friday, February 7) at 8:30 a.m. Eastern Time. To listen to a live webcast or replay of the call, visit the investor relations page on the Company's website at investor.mt.com. The presentation referenced on the conference call will be located on the website prior to the call.

    METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.

    Forward-Looking Statements Disclaimer

    You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth, inflation, ongoing developments related to Ukraine, and the conflict in the Middle East. You can identify forward-looking statements by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential," or "continue."

    We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position, pricing, capital expenditures, cash flow, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, and the impact of inflation, ongoing developments related to Ukraine, and the conflict in the Middle East on our business.

    Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including inflation, ongoing developments related to Ukraine, and the conflict in the Middle East. See in particular "Factors Affecting Our Future Operating Results" and "Management's Discussion and Analysis of Financial Condition and Results of Operations."

     
    METTLER-TOLEDO INTERNATIONAL INC.
    CONSOLIDATED STATEMENTS OF OPERATIONS
    (amounts in thousands except share data)
    (unaudited)
     

    Three months ended

     

     

     

     

     

    Three months ended

     

     

    December 31, 2024

     

     

     

    % of sales

     

    December 31, 2023

     

    % of sales

     
    Net sales

    $

    1,045,127

     

    (a)

    100.0

     

    $

    934,992

     

    100.0

     

    Cost of sales

     

    405,812

     

    38.8

     

     

    383,354

     

    41.0

     

    Gross profit

     

    639,315

     

    61.2

     

     

    551,638

     

    59.0

     

     
    Research and development

     

    50,054

     

    4.8

     

     

    46,435

     

    5.0

     

    Selling, general and administrative

     

    237,340

     

    22.7

     

     

    223,427

     

    23.9

     

    Amortization

     

    18,220

     

    1.8

     

     

    18,078

     

    1.9

     

    Interest expense

     

    17,850

     

    1.7

     

     

    19,655

     

    2.1

     

    Restructuring charges

     

    2,147

     

    0.2

     

     

    13,055

     

    1.4

     

    Other charges (income), net

     

    (843

    )

    (0.1

    )

     

    (1,568

    )

    (0.2

    )

    Earnings before taxes

     

    314,547

     

    30.1

     

     

    232,556

     

    24.9

     

     
    Provision for taxes

     

    62,246

     

    6.0

     

     

    47,761

     

    5.1

     

    Net earnings

    $

    252,301

     

    24.1

     

    $

    184,795

     

    19.8

     

     
    Basic earnings per common share:
    Net earnings

    $

    12.00

     

    $

    8.56

     

    Weighted average number of common shares

     

    21,024,024

     

     

    21,593,616

     

     
    Diluted earnings per common share:
    Net earnings

    $

    11.96

     

    $

    8.52

     

    Weighted average number of common

     

    21,101,360

     

     

    21,687,577

     

    and common equivalent shares
     
    Note:

    (a) Local currency sales increased 12% as compared to the same period in 2023.

     

    RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three months ended

     

     

     

     

     

    Three months ended

     

     

     

     

    December 31, 2024

     

     

     

    % of sales

     

    December 31, 2023

     

    % of sales

     
    Earnings before taxes

    $

    314,547

     

    $

    232,556

     

    Amortization

     

    18,220

     

     

    18,078

     

    Interest expense

     

    17,850

     

     

    19,655

     

    Restructuring charges

     

    2,147

     

     

    13,055

     

    Other charges (income), net

     

    (843

    )

     

    (1,568

    )

    Adjusted operating profit

    $

    351,921

     

    (b)

    33.7

     

    $

    281,776

     

    30.1

     

     
    Note:

    (b) Adjusted operating profit increased 25% as compared to the same period in 2023.

     

    METTLER-TOLEDO INTERNATIONAL INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (amounts in thousands except share data)

    (unaudited)

     

     

     

     

     

     

     

     

     

     

     

     

     

    Twelve months ended

     

     

     

     

     

    Twelve months ended

     

     

     

     

    December 31, 2024

     

     

     

    % of sales

     

    December 31, 2023

     

    % of sales

     
    Net sales

    $

    3,872,361

     

    (a)

    100.0

     

    $

    3,788,309

     

    100.0

     

    Cost of sales

     

    1,546,778

     

    39.9

     

     

    1,547,023

     

    40.8

     

    Gross profit

     

    2,325,583

     

    60.1

     

     

    2,241,286

     

    59.2

     

     
    Research and development

     

    189,357

     

    4.9

     

     

    185,284

     

    4.9

     

    Selling, general and administrative

     

    936,303

     

    24.2

     

     

    904,106

     

    23.9

     

    Amortization

     

    72,869

     

    1.9

     

     

    72,213

     

    1.9

     

    Interest expense

     

    74,631

     

    1.9

     

     

    77,366

     

    2.0

     

    Restructuring charges

     

    19,771

     

    0.5

     

     

    32,735

     

    0.9

     

    Other charges (income), net

     

    (4,571

    )

    (0.1

    )

     

    (4,146

    )

    (0.1

    )

    Earnings before taxes

     

    1,037,223

     

    26.8

     

     

    973,728

     

    25.7

     

     
    Provision for taxes

     

    174,083

     

    4.5

     

     

    184,950

     

    4.9

     

    Net earnings

    $

    863,140

     

    22.3

     

    $

    788,778

     

    20.8

     

     
    Basic earnings per common share:
    Net earnings

    $

    40.67

     

    $

    36.10

     

    Weighted average number of common shares

     

    21,221,839

     

     

    21,848,122

     

     
    Diluted earnings per common share:
    Net earnings

    $

    40.48

     

    $

    35.90

     

    Weighted average number of common

     

    21,320,641

     

     

    21,971,528

     

    and common equivalent shares
     
    Note:

    (a) Local currency sales increased 3% as compared to the same period in 2023.

     
    RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT
     

    Twelve months ended

     

     

     

     

     

    Twelve months ended

     

     

    December 31, 2024

     

     

     

    % of sales

     

    December 31, 2023

     

    % of sales

     
    Earnings before taxes

    $

    1,037,223

     

    $

    973,728

     

    Amortization

     

    72,869

     

     

    72,213

     

    Interest expense

     

    74,631

     

     

    77,366

     

    Restructuring charges

     

    19,771

     

     

    32,735

     

    Other charges (income), net

     

    (4,571

    )

     

    (4,146

    )

    Adjusted operating profit

    $

    1,199,923

     

    (b)

    31.0

     

    $

    1,151,896

     

    30.4

     

     
    Note:

    (b) Adjusted operating profit increased 4% as compared to the same period in 2023.

     
    METTLER-TOLEDO INTERNATIONAL INC.
    CONDENSED CONSOLIDATED BALANCE SHEETS
    (amounts in thousands)
    (unaudited)
     
     
    December 31, 2024 December 31, 2023
     
    Cash and cash equivalents

    $

    59,362

     

    $

    69,807

     

    Accounts receivable, net

     

    687,112

     

     

    663,893

     

    Inventories

     

    342,274

     

     

    385,865

     

    Other current assets and prepaid expenses

     

    105,158

     

     

    110,638

     

    Total current assets

     

    1,193,906

     

     

    1,230,203

     

     
    Property, plant and equipment, net

     

    770,280

     

     

    803,374

     

    Goodwill and other intangibles assets, net

     

    926,057

     

     

    955,537

     

    Other non-current assets

     

    349,756

     

     

    366,441

     

    Total assets

    $

    3,239,999

     

    $

    3,355,555

     

     
    Short-term borrowings and maturities of long-term debt

    $

    182,623

     

    $

    192,219

     

    Trade accounts payable

     

    215,843

     

     

    210,411

     

    Accrued and other current liabilities

     

    769,727

     

     

    778,452

     

    Total current liabilities

     

    1,168,193

     

     

    1,181,082

     

     
    Long-term debt

     

    1,831,265

     

     

    1,888,620

     

    Other non-current liabilities

     

    367,431

     

     

    435,791

     

    Total liabilities

     

    3,366,889

     

     

    3,505,493

     

     
    Shareholders' equity

     

    (126,890

    )

     

    (149,938

    )

    Total liabilities and shareholders' equity

    $

    3,239,999

     

    $

    3,355,555

     

     
     
    METTLER-TOLEDO INTERNATIONAL INC.
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    (amounts in thousands)
    (unaudited)
     

    Three months ended

     

    Twelve months ended

    December 31,

     

    December 31,

    2024

     

    2023

     

    2024

     

    2023

     
    Cash flow from operating activities:
    Net earnings

    $

    252,301

     

    $

    184,795

     

    $

    863,140

     

    $

    788,778

     

    Adjustments to reconcile net earnings to
    net cash provided by operating activities:
    Depreciation

     

    12,643

     

     

    12,545

     

     

    50,352

     

     

    48,951

     

    Amortization

     

    18,220

     

     

    18,078

     

     

    72,869

     

     

    72,213

     

    Deferred tax benefit

     

    (155

    )

     

    (8,918

    )

     

    (5,216

    )

     

    (13,373

    )

    One-time non-cash discrete tax benefit

     

    -

     

     

    -

     

     

    (22,982

    )

     

    -

     

    Other

     

    6,357

     

     

    5,478

     

     

    19,979

     

     

    17,928

     

    Increase (decrease) in cash resulting from changes in
    operating assets and liabilities

     

    (23,179

    )

     

    69,528

     

     

    (9,796

    )

     

    51,377

     

    Net cash provided by operating activities

     

    266,187

     

     

    281,506

     

     

    968,346

     

     

    965,874

     

     
    Cash flows from investing activities:
    Proceeds from sale of property, plant and equipment

     

    898

     

     

    167

     

     

    1,631

     

     

    835

     

    Purchase of property, plant and equipment

     

    (41,276

    )

     

    (32,416

    )

     

    (103,898

    )

     

    (105,323

    )

    Proceeds from government funding (a)

     

    -

     

     

    3,498

     

     

    -

     

     

    6,094

     

    Acquisitions

     

    (7,618

    )

     

    (5,198

    )

     

    (10,091

    )

     

    (5,811

    )

    Other investing activities

     

    (3,056

    )

     

    (1,552

    )

     

    (7,104

    )

     

    (27,489

    )

    Net cash used in investing activities

     

    (51,052

    )

     

    (35,501

    )

     

    (119,462

    )

     

    (131,694

    )

     
    Cash flows from financing activities:
    Proceeds from borrowings

     

    594,916

     

     

    556,824

     

     

    2,156,565

     

     

    2,126,797

     

    Repayments of borrowings

     

    (598,429

    )

     

    (629,795

    )

     

    (2,175,291

    )

     

    (2,097,023

    )

    Proceeds from exercise of stock options

     

    1,380

     

     

    -

     

     

    23,719

     

     

    19,234

     

    Repurchases of common stock

     

    (212,500

    )

     

    (176,002

    )

     

    (849,997

    )

     

    (900,000

    )

    Payments of excise tax on repurchases of common stock

     

    (8,089

    )

     

    -

     

     

    (8,089

    )

     

    -

     

    Acquisition contingent consideration payment

     

    -

     

     

    -

     

     

    -

     

     

    (7,767

    )

    Other financing activities

     

    (971

    )

     

    -

     

     

    (2,884

    )

     

    (826

    )

    Net cash used in financing activities

     

    (223,693

    )

     

    (248,973

    )

     

    (855,977

    )

     

    (859,585

    )

     
    Effect of exchange rate changes on cash and cash equivalents

     

    (3,654

    )

     

    3,100

     

     

    (3,352

    )

     

    (754

    )

     
    Net increase (decrease) in cash and cash equivalents

     

    (12,212

    )

     

    132

     

     

    (10,445

    )

     

    (26,159

    )

     
    Cash and cash equivalents:
    Beginning of period

     

    71,574

     

     

    69,675

     

     

    69,807

     

     

    95,966

     

    End of period

    $

    59,362

     

    $

    69,807

     

    $

    59,362

     

    $

    69,807

     

     
    RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW
     
    Net cash provided by operating activities

    $

    266,187

     

    $

    281,506

     

    $

    968,346

     

    $

    965,874

     

    Payments in respect of restructuring activities

     

    3,986

     

     

    10,877

     

     

    23,752

     

     

    25,818

     

    Proceeds from sale of property, plant and equipment

     

    898

     

     

    167

     

     

    1,631

     

     

    835

     

    Purchase of property, plant and equipment, net (a)

     

    (41,276

    )

     

    (32,416

    )

     

    (103,898

    )

     

    (97,593

    )

    Acquisition payments (b)

     

    -

     

     

    -

     

     

    -

     

     

    4,775

     

    Transition tax payment

     

    -

     

     

    -

     

     

    10,723

     

     

    8,042

     

    Adjusted free cash flow

    $

    229,795

     

    $

    260,134

     

    $

    900,554

     

    $

    907,751

     

    Notes:

    (a)

    In September 2021, the Company entered into an agreement with the U.S. Department of Defense to increase the domestic production capacity of pipette tips and enhance manufacturing automation and logistics. The Company has received funding of $35.8 million in prior years, which offset capital expenditures. Funding proceeds of $3.5 million during the three months ended December 31, 2023 is excluded from Adjusted free cash flow. Funding proceeds of $6.1 million and the related purchase of property, plant and equipment of $7.7 million for the twelve months ended December 31, 2023 are excluded from Adjusted free cash flow.
     

    (b)

    Includes $4.4 million of the PendoTECH contingent consideration payment that was reported in net cash provided by operating activities as required by U.S. GAAP for the twelve months ended December 31, 2023.
    METTLER-TOLEDO INTERNATIONAL INC.
    OTHER OPERATING STATISTICS
     
     
    SALES GROWTH BY DESTINATION
    (unaudited)
     
    Americas Europe Asia/RoW Total
     
    U.S. Dollar Sales Growth
    Three Months Ended December 31, 2024

    6%

    18%

    15%

    12%

    Twelve Months Ended December 31, 2024

    2%

    8%

    -3%

    2%

     

     

     

     

    Local Currency Sales Growth

     

     

     

     

    Three Months Ended December 31, 2024

    7%

    19%

    14%

    12%

    Twelve Months Ended December 31, 2024

    3%

    8%

    -1%

    3%

     
    Note:
    (a) The Company estimates net sales for the three and twelve months ended December 31, 2024 benefited by 6% and 3%, respectively, from previously delayed shipments from the fourth quarter of 2023. By geographic destination, net sales benefited approximately 4% and 2% in the Americas, 11% and 6% in Europe, and 4% and 2% in Asia/Rest of World for the three and twelve months ended December 31, 2024, respectively.
    RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS
    (unaudited)
     

    Three months ended

     

    Twelve months ended

    December 31,

     

    December 31,

    2024

     

     

    2023

     

     

    % Growth

     

    2024

     

     

     

    2023

     

     

    % Growth

     
    EPS as reported, diluted

    $

    11.96

    $

    8.52

    40

    %

    $

    40.48

     

    $

    35.90

    13

    %

     
    Purchased intangible amortization, net of tax

     

    0.24

    (a)

     

    0.23

    (a)

     

    0.94

     

    (a)

     

    0.93

    (a)
    Restructuring and other, net of tax

     

    0.09

    (b)

     

    0.49

    (b)

     

    0.76

     

    (b)

     

    1.20

    (b)
    Income tax expense

     

    0.12

    (c)

     

    0.16

    (c)

     

    (1.07

    )

    (c)

     

    -

    (c)
     
    Adjusted EPS, diluted

    $

    12.41

    $

    9.40

    32

    %

    $

    41.11

     

    $

    38.03

    8

    %

     
    Notes:

    (a)

    Represents the EPS impact of purchased intangibles amortization of $6.4 million ($5.0 million net of tax) and $6.5 million ($5.0 million net of tax) for the three months ended December 31, 2024 and 2023, and $25.9 million ($20.1 million net of tax) and $26.4 million ($20.4 million net of tax) for the twelve months ended December 31, 2024 and 2023, respectively.
     

    (b)

     

    Represents the EPS impact of restructuring charges of $2.1 million ($1.7 million after tax) and $13.1 million ($10.6 million after tax) for the three months ended December 31, 2024 and 2023, and $19.8 million ($16.0 million after tax) and $32.7 million ($26.5 million after tax) for the twelve months ended December 31, 2024 and 2023, respectively, which primarily include employee related costs; and other costs of $0.3 million ($0.3 million after tax) for the three and twelve months ended December 31, 2024.
     

    (c)

    Represents the EPS impact of the difference between our quarterly and estimated annual tax rate before non-recurring discrete items during the three and twelve months ended December 31, 2024 and 2023 due to the timing of excess tax benefits associated with stock option exercises. Also includes a reported EPS reduction of $1.07 for the twelve months ended December 31, 2024 for a non-cash discrete tax benefit resulting from the reduction of uncertain tax position liabilities related to the settlement of a tax audit.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250206644068/en/

    Adam Uhlman

    Head of Investor Relations

    METTLER TOLEDO

    Direct: 614-438-4794

    [email protected]

    Get the next $MTD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MTD

    DatePrice TargetRatingAnalyst
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    5/5/2025$1100.00Underperform → Hold
    Jefferies
    4/7/2025$1400.00Neutral → Buy
    Citigroup
    1/2/2025$1375.00 → $1450.00In-line → Outperform
    Evercore ISI
    12/13/2024Peer Perform
    Wolfe Research
    12/11/2024$1200.00 → $1300.00Sell → Neutral
    Citigroup
    8/28/2024$1400.00Equal Weight
    Wells Fargo
    6/3/2024$1250.00Underperform
    Jefferies
    More analyst ratings

    $MTD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2025 Healthcare Conference

      Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time). A live webcast of the presentation will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide

      4/25/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,110.00

      5/5/25 8:42:51 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,100.00

      5/5/25 8:26:45 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Citigroup with a new price target

      Citigroup upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,400.00

      4/7/25 8:41:57 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Leadership Updates

    Live Leadership Updates

    See more
    • Mettler-Toledo International Inc. Announces Change to Board of Directors

      Columbus, OH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) announced today that Olivier Filliol informed the Company that he will not stand for re-election to the Board of Directors in May 2023. Mr. Filliol joined the Board in 2009 and served as President and CEO from January 1, 2008 through March 31, 2021.  Robert F. Spoerry, Chair of the Board, stated, "We want to sincerely thank Olivier for his many highly valuable contributions, and we are grateful for the unique expertise that he has brought to the Company. Olivier was instrumental in ensuring a successful CEO transition to Patrick Kaltenbach, which positions the Company well to continue its successf

      11/23/22 8:00:00 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    SEC Filings

    See more

    $MTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/6/25 11:25:47 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 10-Q filed by Mettler-Toledo International Inc.

      10-Q - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/2/25 11:01:00 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/1/25 5:02:22 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      11/15/23 9:00:20 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Financials

    Live finance-specific insights

    See more
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Reports Fourth Quarter 2024 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2024. Provided below are the highlights: Reported and local currency sales increased 12% compared with the prior year. Net earnings per diluted share as reported (EPS) were $11.96, compared with $8.52 in the prior-year period. Adjusted EPS was $12.41, an increase of 32% over the prior-year amount of $9.40. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "We had a strong finish to the year as we capitalized on very good customer deman

      2/6/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Graham-Bryce Susan claimed ownership of 338 shares (SEC Form 3)

      3 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      4/3/25 2:56:39 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Human Resources Magloth Christian exercised 790 shares at a strike of $397.95 and sold $1,037,815 worth of shares (790 units at $1,313.69) (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      2/26/25 12:41:20 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Eur & NA Market Orgs De La Guerroniere Marc sold $1,182,719 worth of shares (888 units at $1,331.89), closing all direct ownership in the company (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      2/13/25 11:09:47 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/13/24 5:09:38 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/23 1:38:29 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/22 5:03:51 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials